Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Portage Biotech Inc. (PRTG) had Free Cash Flow per Share of $-14.78 for the most recently reported fiscal year, ending 2024-03-31.
| Income Statement Financials | |
-- |
|
$-75.34M |
|
-- |
|
-- |
|
$18.25M |
|
$-18.25M |
|
$-67.68M |
|
$-85.93M |
|
$-4.00M |
|
$-75.38M |
|
$-75.38M |
|
$-75.38M |
|
$16.61M |
|
$-18.25M |
|
$-18.20M |
|
0.97M |
|
0.97M |
|
$-77.80 |
|
$-77.80 |
|
| Balance Sheet Financials | |
$7.70M |
|
-- |
|
$0.08M |
|
$7.78M |
|
$2.88M |
|
$0.01M |
|
$1.57M |
|
$4.45M |
|
$3.33M |
|
$3.33M |
|
$3.33M |
|
0.99M |
|
| Cash Flow Statement Financials | |
$-14.30M |
|
$2.81M |
|
$5.97M |
|
$10.54M |
|
$5.03M |
|
$-5.52M |
|
$2.64M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.67 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-14.30M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-2264.40% |
|
-2264.40% |
|
-969.04% |
|
-2259.65% |
|
$3.37 |
|
|
Free Cash Flow per Share |
$-14.78 |
$-14.78 |
|